First Round of Abstract Submission Ends: January 19, 2026
Early Bird Registration Ends: Before January 20, 2026
Drug Discovery is essential in healthcare, focusing on developing new medications to treat a wide range of diseases, including chronic and infectious conditions. We United Scientific Group (USG) offers a vital platform for researchers, industry professionals, and academics to converge and share insights on these advancements in drug discovery and lead optimization in San Francisco, CA.
After nine successful editions, we are thrilled to announce the Tenth edition of the International Conference on Drug Discovery and Lead Optimization set to take place from October 7-9, 2026 in the vibrant city of San Francisco, CA. Following the success of our previous Nine editions, we are excited to once again bring together a diverse and dynamic group of scientists, researchers, industry experts, and students for a stimulating series of presentations, discussions, and networking opportunities.
Covering a wide range of topics including novel drug targets, innovative technologies, clinical trial methodologies, and regulatory challenges the conference features Plenary presentations, keynote presentations, poster presentations and collaborations led by experts across the world.
Attendees have the opportunity to network, discuss emerging trends, and explore potential partnerships. This year’s conference promises to be a landmark event in the field of drug discovery. As the landscape of drug development continues to evolve, the need for innovative solutions and interdisciplinary collaboration has never been greater.
Knowledge and Insights
Networking
Partnerships
Access to Decision-Makers
Cutting-Edge Science
Professional Development
Inspiration
Exposure to New Ideas
Stay Competitive
Share Your Work
Drug Discovery-2026 dedicates to create a stage for exchanging the latest research results and sharing the advanced research methods.
Copyright © USG United Scientific Group. All Right Reserved | Privacy Policy | Terms & Conditions
